Dermata Therapeutics annual current ratio
2020
2021
2022
2023
2024
2025
Dermata Therapeutics Current Ratio Growth & History (DRMA)
Dermata Therapeutics's current ratio was 4.79 for fiscal 2025.
View full Dermata Therapeutics company overviewDermata Therapeutics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 4.79 | 3.00 | +167.61% |
| 2024 | 2024-12-31 | 1.79 | −3.12 | −63.55% |
| 2023 | 2023-12-31 | 4.91 | −2.61 | −34.71% |
| 2022 | 2022-12-31 | 7.53 | −0.14 | −1.78% |
| 2021 | 2021-12-31 | 7.66 | 7.50 | +4688.68% |
| 2020 | 2020-12-31 | 0.16 | — | — |
Dermata Therapeutics quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 2.81 | −3.66 | −56.53% |
| Q1 2026 | 2026-03-31 | 7.09 | 3.39 | +91.66% |
| Q4 2025 | 2025-12-31 | 4.79 | — | — |
| Q3 2025 | 2025-09-30 | 4.56 | — | — |
| Q2 2025 | 2025-06-30 | 6.47 | — | — |
| Q1 2025 | 2025-03-31 | 3.70 | — | — |
| Q4 2021 | 2021-12-31 | 7.66 | 7.50 | +4688.68% |
| Q3 2021 | 2021-09-30 | 11.45 | — | — |
| Q2 2021 | 2021-06-30 | 0.69 | — | — |
| Q4 2020 | 2020-12-31 | 0.16 | — | — |
Dermata Therapeutics current ratio trends
Over the last five fiscal years, Dermata Therapeutics's current ratio increased from 0.16 to 4.79, a change of 4.63. The latest reported quarter, Q2 2026, shows 2.81.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dermata Therapeutics source filings ↗